Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
VITARINE's TRIAMTERENE/HYDROCHLOROTHIAZIDE WILL BE ONLY GENERIC VERSION OF MYLAN's MAXZIDE ON MARKET UNTIL APRIL 17; FIRM's ANDA APPROVED DEC. 8
Dec 14 1987
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet